AU2019296854A1 - Use of mannuronic diacid composition in treatment of vascular dementia - Google Patents

Use of mannuronic diacid composition in treatment of vascular dementia Download PDF

Info

Publication number
AU2019296854A1
AU2019296854A1 AU2019296854A AU2019296854A AU2019296854A1 AU 2019296854 A1 AU2019296854 A1 AU 2019296854A1 AU 2019296854 A AU2019296854 A AU 2019296854A AU 2019296854 A AU2019296854 A AU 2019296854A AU 2019296854 A1 AU2019296854 A1 AU 2019296854A1
Authority
AU
Australia
Prior art keywords
mannuronic
composition
total weight
diacids
vascular dementia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019296854A
Other languages
English (en)
Inventor
Jian Ding
Xiaoguang DU
Meiyu Geng
Xianliang Xin
Zhenqing ZHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Shanghai Green Valley Pharmaceutical Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Publication of AU2019296854A1 publication Critical patent/AU2019296854A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2019296854A 2018-06-29 2019-06-28 Use of mannuronic diacid composition in treatment of vascular dementia Abandoned AU2019296854A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810711863.8A CN110652523A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用
CN201810711863.8 2018-06-29
PCT/CN2019/093813 WO2020001643A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用

Publications (1)

Publication Number Publication Date
AU2019296854A1 true AU2019296854A1 (en) 2021-01-28

Family

ID=68985857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019296854A Abandoned AU2019296854A1 (en) 2018-06-29 2019-06-28 Use of mannuronic diacid composition in treatment of vascular dementia

Country Status (7)

Country Link
US (1) US11406651B2 (https=)
EP (1) EP3815694A4 (https=)
JP (1) JP2021528458A (https=)
KR (1) KR20210040039A (https=)
CN (1) CN110652523A (https=)
AU (1) AU2019296854A1 (https=)
WO (1) WO2020001643A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN106344592A (zh) 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
CN106344593B (zh) * 2015-07-17 2020-01-10 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
JP6977059B2 (ja) * 2016-12-30 2021-12-08 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. マンヌロン二酸の組成物

Also Published As

Publication number Publication date
WO2020001643A1 (zh) 2020-01-02
EP3815694A4 (en) 2022-03-02
US11406651B2 (en) 2022-08-09
KR20210040039A (ko) 2021-04-12
US20210268006A1 (en) 2021-09-02
EP3815694A1 (en) 2021-05-05
CN110652523A (zh) 2020-01-07
JP2021528458A (ja) 2021-10-21

Similar Documents

Publication Publication Date Title
JP6977059B2 (ja) マンヌロン二酸の組成物
AU2019296843B2 (en) Composition of alginate oligosaccharide diacids
CN106344593B (zh) 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
US11406659B2 (en) Use of mannuronic diacid composition in treatment of inflammation
US11406651B2 (en) Use of mannuronic diacid composition in treatment of vascular dementia
US11406654B2 (en) Use of mannuronic diacid composition in treatment of Parkinson's disease
HK40014916A (en) Use of a composition of oligomeric mannuronic diacid for treating vascular dementia
AU2019296855A1 (en) Application of composition of mannuronic diacid in treating diabetes
US11406653B2 (en) Use of mannuronic diacid composition in treatment of pain
HK40014917A (en) Use of a composition of oligomeric mannuronic diacid for treating parkinson's disease
HK40016251A (en) Use of a composition of mannuronic diacids in the treatment of pain

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period